Steven Harries

Steven Harries is a seasoned professional in the oncology and rare disease sectors, currently serving as a Rare Disease Account Manager at Recordati Rare Diseases Inc. since June 2022. Harries has held various strategic account management roles, including positions at Clinigen Group and Prometheus Laboratories, where responsibilities included promoting Proleukin for metastatic cancers and managing diverse portfolios in molecular diagnostics. Previous experience includes leadership roles at Myriad Genetics, Genomic Health, Biogen Idec, and GlaxoSmithKline, where Steven contributed to the launch and business development of several innovative treatments. Steven Harries holds a BA in Political Science and Government from the University of Utah.